HUEMOELLER JOHN WALTER II 4
4 · AXIM BIOTECHNOLOGIES, INC. · Filed Sep 23, 2022
Insider Transaction Report
Form 4
HUEMOELLER JOHN WALTER II
Director
Transactions
- Purchase
Common Stock
2020-03-19+6,000,000→ 6,000,000 total
Footnotes (1)
- [F1]Reporting Person acquired the shares pursuant to a share exchange with the Issuer whereby Reporting Person exchanged 100% of the Sapphire Biotech, Inc. shares common stock held by Reporting Person for 6,000,000 shares of common stock of the Issuer.